Li Kang Biomedical Co Ltd (6242) — Cash Flow-to-Debt Ratio
Li Kang Biomedical Co Ltd (6242) has a Cash Flow-to-Debt Ratio of 0.30x as of December 2025, meaning its operating cash flow of NT$67.23 Million could theoretically repay 0% of its total liabilities (NT$221.82 Million) in one year. Check how aggressively does Li Kang Biomedical Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Li Kang Biomedical Co Ltd Cash Flow-to-Debt Ratio (2002–2025)
Historical debt coverage capacity for Li Kang Biomedical Co Ltd across 15 annual periods. Also explore Li Kang Biomedical Co Ltd balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Li Kang Biomedical Co Ltd (2002–2025)
Year-by-year debt coverage analysis for Li Kang Biomedical Co Ltd. For market capitalisation and broader financial context, see how much is Li Kang Biomedical Co Ltd worth.
| Year | CF-to-Debt Ratio | Operating CF (TWD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.42x | NT$92.15 Million | NT$221.82 Million | ▲ +14.3% |
| 2024 | 0.36x | NT$65.38 Million | NT$179.93 Million | ▼ -26.0% |
| 2023 | 0.49x | NT$96.74 Million | NT$196.97 Million | ▼ -62.9% |
| 2022 | 1.32x | NT$157.24 Million | NT$118.70 Million | ▲ +171.9% |
| 2021 | 0.49x | NT$60.45 Million | NT$124.07 Million | ▼ -18.6% |
| 2020 | 0.60x | NT$81.67 Million | NT$136.46 Million | ▼ -7.5% |
| 2019 | 0.65x | NT$92.56 Million | NT$143.00 Million | ▼ -12.3% |
| 2018 | 0.74x | NT$105.53 Million | NT$142.93 Million | ▲ +0.4% |
| 2017 | 0.74x | NT$110.61 Million | NT$150.38 Million | ▲ +42.0% |
| 2016 | 0.52x | NT$110.82 Million | NT$213.96 Million | ▲ +99.7% |
| 2015 | 0.26x | NT$63.91 Million | NT$246.44 Million | ▼ -39.7% |
| 2014 | 0.43x | NT$41.66 Million | NT$96.93 Million | ▲ +84.5% |
| 2009 | 0.23x | NT$28.97 Million | NT$124.35 Million | ▲ +1686.7% |
| 2003 | 0.01x | NT$5.63 Million | NT$432.09 Million | ▼ -88.1% |
| 2002 | 0.11x | NT$45.87 Million | NT$418.31 Million | — |